受教育及工作經(jīng)歷
科研方向
科研項(xiàng)目
發(fā)表論文
小組成員
聯(lián)系方式
2024-今 上海交通大學(xué)基礎(chǔ)醫(yī)學(xué)院常務(wù)副院長(zhǎng)
2020-2024 上海交通大學(xué)基礎(chǔ)醫(yī)學(xué)院副院長(zhǎng)
2020-今 腫瘤系統(tǒng)醫(yī)學(xué)全國(guó)重點(diǎn)實(shí)驗(yàn)室副主任
2016-今 上海交通大學(xué)醫(yī)學(xué)院上海市免疫學(xué)研究所 研究員(PI),,博士生導(dǎo)師
2012-2016 美國(guó)MD Anderson Cancer Center博士后
2007-2012 中國(guó)農(nóng)業(yè)大學(xué) 博士(Ph.D.)
2003-2007 山東農(nóng)業(yè)大學(xué) 理學(xué)學(xué)士(B.S.)
腫瘤免疫治療已經(jīng)被臨床應(yīng)用治療惡性腫瘤,,在一些患者中具有顯著療效,,但是依然存在臨床響應(yīng)率低的難題,。免疫細(xì)胞活性受到細(xì)胞代謝調(diào)控,,研究腫瘤免疫的代謝調(diào)控機(jī)制將為進(jìn)一步提高腫瘤免疫治療療效提供新的思路和策略,。課題組主要圍繞腫瘤免疫應(yīng)答與耐受的代謝調(diào)控機(jī)制,采用分子,、細(xì)胞,、生化、動(dòng)物模型,、臨床樣本等,,研究參與調(diào)控腫瘤免疫代謝的關(guān)鍵因子及其作用機(jī)制,探索干預(yù)腫瘤免疫代謝提高腫瘤免疫應(yīng)答的免疫治療策略,。
項(xiàng)目編號(hào) |
項(xiàng)目類型 |
項(xiàng)目名稱 |
起止年月 |
備注 |
82430054 |
國(guó)家自然科學(xué)基金重點(diǎn)項(xiàng)目 |
衰老引起的瘦素水平下降促進(jìn)腫瘤浸潤(rùn)CD8+T細(xì)胞功能障礙的機(jī)制與治療策略研究 |
2025/1~2029/12 |
項(xiàng)目負(fù)責(zé)人 |
82225020 |
國(guó)家自然科學(xué)基金杰青項(xiàng)目 |
腫瘤免疫與糖代謝 |
2023-01~2027-12 |
項(xiàng)目負(fù)責(zé)人 |
2021YFA1301400 |
國(guó)家重點(diǎn)研發(fā)計(jì)劃 |
呼吸道病毒感染免疫應(yīng)答的全景研究 |
2021-12~2026-11 |
研究骨干 |
81930040 |
國(guó)家自然科學(xué)基金重點(diǎn)項(xiàng)目 |
T細(xì)胞的糖代謝在結(jié)直腸癌發(fā)生中的作用機(jī)制 |
2020/1~2024/12 |
項(xiàng)目負(fù)責(zé)人 |
31922025 |
國(guó)家自然科學(xué)基金優(yōu)秀青年基金 |
糖代謝與腫瘤免疫 |
2020/1~2022/12 |
項(xiàng)目負(fù)責(zé)人 |
2020YFA08003603 |
國(guó)家重點(diǎn)研發(fā)計(jì)劃 |
組織器官代謝可塑性與記憶的調(diào)控機(jī)制及其生理病理意義 |
2020/12-2025/11 |
研究骨干 |
31870884 |
國(guó)家自然科學(xué)基金面上項(xiàng)目 |
泛素連接酶ZFP91在CD8+T細(xì)胞抗腫瘤功能中的調(diào)控機(jī)制 |
2019/1~2022/12 |
項(xiàng)目負(fù)責(zé)人 |
1) Ding R#, Yu X #, Hu Z #, Dong Y, Huang H, Zhang Y, Han Q, Ni ZY*, Zhao R*, Ye Y* and Zou Q*. Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells. Immunity, 2024, 57(3), 528–540. (IF: 32.4)
2) Du X, Jie ZL, and Zou Q. Microbiota alert: Proteobacteria consume arginine to dampen omental antitumor immunity. Cell Host & Microbe, 2024, July10, 32(7), 1045-1047. (IF:20.6)
3) Zhang Y#, Yu X#, Bao R#, Huang H, Gu C, Lv Q, Han Q, Du X, Zhao XY, Ye Y*, Zhao R*, Sun J*, Zou Q*. Dietary fructose-mediated adipocyte metabolism drives antitumor CD8+ T cell responses. Cell Metabolism, 2023,35(12):2107-2118. (IF: 29.0)
4) Wang A#, Huang H#, Shi JH, Yu X, Ding R, Zhang Y, Han Q, Ni ZY*, Li X*, Zhao R*, Zou Q*. USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis. Journal of Clinical Investigation, 2023 Dec 1;133(23):e169365. (IF: 15.9)
5) Hu Z*, Yu X, Ding R, Liu B, Gu C, Pan X, Han Q, Zhang Y, Wan J, Cui X*, Sun J*, Zou Q*. Glycolysis drives STING signaling to facilitate dendritic cell antitumor function. Journal of Clinical Investigation, 2023 Apr 3;133(7):e166031. (IF: 15.9)
6) Wu Z, Huang H, Han Q, Hu Z, Teng XL, Ding R, Ye Y, Yu X*, Zhao R*, Wang Z*, Zou Q*. SENP7 senses oxidative stress to sustain metabolic fitness and antitumor functions of CD8+ T cells. Journal of Clinical Investigation, 2022 Apr 1;132(7):e155224. (IF: 19.456)
7) Wang F, Zhang Y, Yu X, Teng XL, Ding R, Hu Z, Wang A, Wang Z*, Ye Y*, Zou Q*. ZFP91 disturbs metabolic fitness and antitumor activity of tumor-infiltrating T cells. Journal of Clinical Investigation. 2021 Oct 1;131(19):e144318. (IF: 14.808)
8) Hu Z#, Teng XL#, Zhang T, Yu X, Ding R, Yi J, Deng L*, Wang Z*, Zou Q*. SENP3 senses oxidative stress to facilitate STING-dependent dendritic cell antitumor function. Molecular Cell, 2021, Mar 4;81(5):940-952.e5. (IF: 17.970)
9) Wang A#, Ding L#, Wu Z, Ding R, Teng XL, Wang F, Hu Z, Chen L*, Yu X*, Zou Q*. ZFP91 is required for the maintenance of regulatory T cell homeostasis and function. The Journal of Experimental Medicine, 2021 Feb 1;218(2):e20201217. (IF: 14.307)
10) Hu Z#, Qu G#, Yu X#, Jiang H, Teng X-L, Ding L, Hu Q, Guo X, Zhou Y, Wang F, Li H-B, Chen L, Jiang J, Su B*, Liu J*, Zou Q*. Acylglycerol Kinase Maintains Metabolic State and Immune Responses of CD8+ T Cells. Cell Metabolism, 2019, 30(2):290-302. (IF: 27.287)
11) Yu X#, Teng X-L#, Wang F#, Zheng Y#, Qu G, Zhou Y, Hu Z, Wu Z, Chang Y, Chen L, Li H-B, Su B, Lu L*, Liu Z*, Sun S-C*, Zou Q*. Metabolic control of regulatory T cell stability and function by TRAF3IP3 at the lysosome. The Journal of Experimental Medicine, 2018, 215(9):2463-2476. (IF: 14.307)
12) Yu X#, Lao Y#, Teng X-L#, Li S, Zhou Y, Wang F, Guo X, Deng S, Chang Y, Wu X, Liu Z, Chen L, Lu L, Cheng J, Li B, Su B, Jiang J, Li H-B*, Huang C*, Yi J*, Zou Q*. SENP3 maintains the stability and function of regulatory T cells via BACH2 deSUMOylation. Nature Communications, 2018, 9:3157. (IF: 14.919)
13) Xiao Y#, Zou Q#, Xie X#, Liu T, Li H, Jie Z, Jin J, Hu H, Manyam G, Zhang L, Cheng X, Wang H, Marie I, Levy D, Watowich S, and Sun S-C*. The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity. The Journal of Experimental Medicine, 2017, 214(5):1493-1507.
辦公室地址: |
上海市重慶南路280號(hào)5號(hào)樓9樓907室 |
辦公室電話: |
021-64666150 |
實(shí)驗(yàn)室地址: |
上海市重慶南路280號(hào)5號(hào)樓9樓912室 |
實(shí)驗(yàn)室電話: |
021-63846590-776662 |
郵 箱: |
[email protected] |
|